Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Cell Reports. Medicine|March 31, 2026
Single-cell spatial transcriptomics reveals tumor microenvironment heterogeneity in primary and lymph node-metastatic small cell lung cancerZicheng Zhang, Dongfang Wu, Ruanqi Chen, et al.Disease Markers|March 3, 2022
Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic AnalysisPeng Cao, Fan Li, Yajie Xiao, et al.Frontiers in Oncology|June 7, 2021
Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case ReportZhilin Luo, Hong Zhang, Yajie Xiao, et al.Biomed Research International|February 18, 2022
Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular SubtypesPeng Cao, Bo Zhao, Yajie Xiao, et al.Cancer Medicine|October 22, 2022
Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancerYanhui Zhu, Hongfei Zhang, Chaohu Pan, et al.Frontiers in Immunology|May 9, 2022
Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature ModelLei Wang, Hongbing Zhang, Chaohu Pan, et al.Cancer Cell International|March 29, 2022
Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patientsKang Li, Jun Liu, Lin Wu, et al.Journal of Translational Medicine|January 16, 2024
A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosisGuiwu Zhuang, Xiaotao Zhang, Wenjing Du, et al.Ebiomedicine|March 15, 2023
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trialGuoqing Zhang, Jing Yuan, Chaohu Pan, et al.Frontiers in Immunology|January 3, 2022
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case SeriesChengjing Zhou, Ting Jiang, Yajie Xiao, et al.Pageof 7